- Home
- BRN vs LIXT Comparison
BRN vs LIXT Comparison
Compare BRN & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- LIXT
- Stock Information
- Founded
- BRN 1956
- LIXT 2005
- Country
- BRN United States
- LIXT United States
- Employees
- BRN N/A
- LIXT N/A
- Industry
- BRN Oil & Gas Production
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- LIXT Health Care
- Exchange
- BRN Nasdaq
- LIXT Nasdaq
- Market Cap
- BRN 11.4M
- LIXT 12.4M
- IPO Year
- BRN N/A
- LIXT N/A
- Fundamental
- Price
- BRN $1.16
- LIXT $5.45
- Analyst Decision
- BRN
- LIXT
- Analyst Count
- BRN 0
- LIXT 0
- Target Price
- BRN N/A
- LIXT N/A
- AVG Volume (30 Days)
- BRN 29.6K
- LIXT 167.8K
- Earning Date
- BRN 08-13-2025
- LIXT 11-11-2025
- Dividend Yield
- BRN N/A
- LIXT N/A
- EPS Growth
- BRN N/A
- LIXT N/A
- EPS
- BRN N/A
- LIXT N/A
- Revenue
- BRN $18,073,000.00
- LIXT N/A
- Revenue This Year
- BRN N/A
- LIXT N/A
- Revenue Next Year
- BRN N/A
- LIXT N/A
- P/E Ratio
- BRN N/A
- LIXT N/A
- Revenue Growth
- BRN N/A
- LIXT N/A
- 52 Week Low
- BRN $1.08
- LIXT $0.64
- 52 Week High
- BRN $2.40
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- BRN 51.10
- LIXT 62.11
- Support Level
- BRN $1.08
- LIXT $5.40
- Resistance Level
- BRN $1.19
- LIXT $6.26
- Average True Range (ATR)
- BRN 0.05
- LIXT 0.61
- MACD
- BRN 0.00
- LIXT 0.11
- Stochastic Oscillator
- BRN 62.50
- LIXT 65.97
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.